AbstractCommunication between endothelial and smooth muscle cells (SMCs) contributes to atherosclerosis induced by atherogenic factors, such as oxide LDL. Asymmetric dimethylarginine (ADMA), a newly found cardiovascular risk factor, accumulates in the culture medium of oxide LDL (oxLDL)-treated endothelial cells and positively correlates with atherosclerosis. This study demonstrates that ADMA mediates the communication between endothelial cells and SMCs induced by oxLDL leading to SMC migration. In addition, the present study suggests exogenous ADMA directly induces SMC migration via p38 and ERK1/2 MAPK signaling transduction way. Investigations to identify the factors regulating VSMC migration may provide novel insights into atherosclerosi...
Despite monumental progress in both molecular and interventional cardiology, atherosclerosis remains...
ObjectiveVascular smooth muscle cell (SMC) migration is critical to the development of atheroscleros...
Angiotensin II (Ang II) and platelet-derived growth factor-BB (PDGF-BB) are associated with excessiv...
AbstractCommunication between endothelial and smooth muscle cells (SMCs) contributes to atherosclero...
Copyright © 2014 Yi-ming Zhou et al. This is an open access article distributed under the Creative C...
Atherosclerosis is a chronic cardiovascular disease which increases risk of major cardiovascular eve...
Asymmetric dimethylarginine (ADMA) induces vascular smooth muscle cells (VSMCs) migration. VSMC phen...
Atherosclerosis is a chronic progressive inflammatory process that can eventually lead to cardiovasc...
Atherosclerotic coronary heart disease is the leading cause of morbidity and mortality in industrial...
Objective- This study investigated whether differences exist in atherogen-induced migratory behavior...
We explored the role of asymmetrical dimethylarginine (ADMA) as a cause of endothelial dysfunction i...
AbstractAdvanced glycation end-products (AGEs) play key roles in the development of diabetic vascula...
Background Asymmetric dimethylarginine (ADMA) is a naturally occurring inhibitor of nitric oxide syn...
Background: Asymmetric dimethylarginine (ADMA) is an endogenous nitric oxide synthase inhibitor and ...
Background: Asymmetric dimethylarginine (ADMA) is a naturally occurring inhibitor of nitric oxide sy...
Despite monumental progress in both molecular and interventional cardiology, atherosclerosis remains...
ObjectiveVascular smooth muscle cell (SMC) migration is critical to the development of atheroscleros...
Angiotensin II (Ang II) and platelet-derived growth factor-BB (PDGF-BB) are associated with excessiv...
AbstractCommunication between endothelial and smooth muscle cells (SMCs) contributes to atherosclero...
Copyright © 2014 Yi-ming Zhou et al. This is an open access article distributed under the Creative C...
Atherosclerosis is a chronic cardiovascular disease which increases risk of major cardiovascular eve...
Asymmetric dimethylarginine (ADMA) induces vascular smooth muscle cells (VSMCs) migration. VSMC phen...
Atherosclerosis is a chronic progressive inflammatory process that can eventually lead to cardiovasc...
Atherosclerotic coronary heart disease is the leading cause of morbidity and mortality in industrial...
Objective- This study investigated whether differences exist in atherogen-induced migratory behavior...
We explored the role of asymmetrical dimethylarginine (ADMA) as a cause of endothelial dysfunction i...
AbstractAdvanced glycation end-products (AGEs) play key roles in the development of diabetic vascula...
Background Asymmetric dimethylarginine (ADMA) is a naturally occurring inhibitor of nitric oxide syn...
Background: Asymmetric dimethylarginine (ADMA) is an endogenous nitric oxide synthase inhibitor and ...
Background: Asymmetric dimethylarginine (ADMA) is a naturally occurring inhibitor of nitric oxide sy...
Despite monumental progress in both molecular and interventional cardiology, atherosclerosis remains...
ObjectiveVascular smooth muscle cell (SMC) migration is critical to the development of atheroscleros...
Angiotensin II (Ang II) and platelet-derived growth factor-BB (PDGF-BB) are associated with excessiv...